Temperature-dependent Changes in Cardiovascular Parameters During Warm Water Footbaths in Healthy Women
1 other identifier
interventional
28
1 country
1
Brief Summary
A study to explore whether different temperatures of warm water footbaths have different effects on the cardiovascular system, the autonomic nervous system and the general well-being of healthy women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedStudy Start
First participant enrolled
October 26, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedJuly 16, 2021
July 1, 2021
7 months
September 29, 2020
July 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pressure Rate Product (PRP) at timepoint t5 (footbath minute 21-30)
Pressure Rate Product (PRP), calculated from systolic blood pressure (measured with the Mobil-O-Graph® PWA) and heart rate (measured with the Bittium Faros 360TM ECG recorder) at timepoint 5 (t5 = mean of the measurements recorded from minute 21 to minute 30 of the footbath).
Timepoint 5 (t5 = mean of the measurements recorded from minute 21-30 of the 30-minute footbath)
Secondary Outcomes (52)
Change in Pressure Rate Product (PRP) at timepoints t1 (minute 1-10 of the pre-intervention rest period), t3 (minute 1-10 of the footbath), t4 (minute 11-20 of the footbath), and t7 (minute 1-10 of the post-intervention rest period).
Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.
Heart rate variability (HRV) analysis: Change in SDNN
Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.
Change in pNN50
Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.
Change in HF
Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.
Change in LF
Physiological parameters are measured continuously (Vitaguard® VG 3100, GETEMED; Bittium Faros 360TM) and every 2 min (Mobil-O-Graph® PWA) for a total duration of 50 min.
- +47 more secondary outcomes
Other Outcomes (2)
Change in warmth perception and skin stimulus at the feet during the footbath
Up to 30 minutes.
Preferred footbath
10 minutes.
Study Arms (4)
38° C footbath
EXPERIMENTALFootbath with warm water at a constant temperature of 38° C
40° C footbath
EXPERIMENTALFootbath with warm water at a constant temperature of 40° C
42° C footbath
EXPERIMENTALFootbath with warm water at a constant temperature of 42° C
Rising temperature footbath
EXPERIMENTALFootbath with warm water rising from 38° C to 42° C
Interventions
A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water at a constant temperature of 38°C, followed by a ten-minute post-intervention rest period.
A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water at a constant temperature of 40°C, followed by a ten-minute post-intervention rest period.
A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water at a constant temperature of 42°C, followed by a ten-minute post-intervention rest period.
A ten-minute pre-intervention rest period followed by a 30-minute footbath with 16 l of warm water. Water temperature starts at 38°C and is increased by 1°C every 6 minutes, resulting in 42°C after 30 minutes. The footbath is followed by a ten-minute post-intervention rest period.
Eligibility Criteria
You may qualify if:
- Written informed consent
- Age between 18 and 55 years
You may not qualify if:
- Male sex
- Chronic skin lesions at the lower legs or feet
- Varicose veins grade 3 and grade 4 (Marshall stage classification), chronic venous insufficiency
- Cardiac arrhythmia
- Cardiac pacemaker
- Asthma bronchiale
- Consumption of HRV-modulating medication (especially tricyclic antidepressants, beta blockers)
- Pregnancy
- Insufficient knowledge of the German language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arcim Institute
Filderstadt, Baden-Wurttemberg, 70794, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Vagedes, Dr
Arcim Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 29, 2020
First Posted
October 8, 2020
Study Start
October 26, 2020
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
July 16, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The data will be made available upon publication for a duration of three months.
- Access Criteria
- The data will be made available to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal.
Deidentified individual participant data will be made available, in addition to study protocol and informed consent form.